Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

German (DAX) Chemicals Industry Analysis

UpdatedJan 10, 2026
DataAggregated Company Financials
Companies17
  • 7D0.6%
  • 3M1.9%
  • 1Y-1.7%
  • YTD0.7%

The Chemicals industry has stayed flat over the last week. Furthermore, the industry has been flat for the past year as well. As for the next few years, earnings are expected to grow by 38% per annum.

Industry Valuation and Performance

Has the German Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 10 Jan 2026€81.6b€118.9b-€1,065,590,357.0623.3x-76.5x0.7x
Mon, 08 Dec 2025€79.9b€118.9b-€1,065,564,519.0221.4x-75x0.7x
Wed, 05 Nov 2025€79.4b€119.7b-€568,539,876.1719.4x-139.7x0.7x
Fri, 03 Oct 2025€81.8b€120.6b-€417,455,980.1519.8x-196x0.7x
Sun, 31 Aug 2025€85.8b€120.6b-€419,951,359.7422x-204.4x0.7x
Tue, 29 Jul 2025€87.7b€122.0b€1.6b18.4x55.1x0.7x
Thu, 26 Jun 2025€85.7b€122.0b€1.6b19.7x53.9x0.7x
Sat, 24 May 2025€87.7b€122.0b€1.6b18.9x55.1x0.7x
Mon, 21 Apr 2025€85.1b€122.2b€2.1b15.6x39.6x0.7x
Wed, 19 Mar 2025€99.2b€122.1b€1.6b20.1x61.2x0.8x
Fri, 14 Feb 2025€95.2b€122.1b€720.2m23.6x132.2x0.8x
Sun, 12 Jan 2025€82.4b€122.1b€722.6m25.3x114.1x0.7x
Tue, 10 Dec 2024€88.5b€122.1b€722.6m22.9x122.5x0.7x
Thu, 07 Nov 2024€96.9b€128.8b€168.8m16.6x573.8x0.8x
Sat, 05 Oct 2024€104.5b€128.8b-€331,077,792.0016.6x-315.6x0.8x
Mon, 02 Sep 2024€91.9b€122.0b-€352,696,450.0015x-260.5x0.8x
Wed, 31 Jul 2024€88.6b€121.9b-€733,922,620.0012.8x-120.7x0.7x
Fri, 28 Jun 2024€91.8b€123.4b-€574,854,556.0013.8x-159.6x0.7x
Sun, 26 May 2024€92.9b€123.4b-€577,382,780.1714.5x-161x0.8x
Tue, 23 Apr 2024€94.9b€127.2b-€39,147,483.0015.5x-2424.4x0.7x
Thu, 21 Mar 2024€95.9b€127.2b-€31,907,209.0014.1x-3006.1x0.8x
Sat, 17 Feb 2024€88.4b€133.6b-€2,982,235,209.0012.2x-29.6x0.7x
Mon, 15 Jan 2024€86.9b€133.6b-€2,980,615,209.0012.2x-29.1x0.7x
Wed, 13 Dec 2023€89.5b€133.6b-€2,980,615,209.0011.9x-30x0.7x
Fri, 10 Nov 2023€87.9b€134.3b-€2,655,191,209.0011.5x-33.1x0.7x
Sun, 08 Oct 2023€84.3b€143.9b-€701,228,845.009.9x-120.3x0.6x
Tue, 05 Sep 2023€91.1b€143.9b-€699,067,207.0010.5x-130.3x0.6x
Thu, 03 Aug 2023€92.4b€146.6b€704.2m11.1x131.1x0.6x
Sat, 01 Jul 2023€88.1b€152.7b€2.6b11.9x34.5x0.6x
Mon, 29 May 2023€91.5b€152.7b€2.6b12.4x35.9x0.6x
Wed, 26 Apr 2023€95.8b€157.4b€3.3b12.1x29.2x0.6x
Fri, 24 Mar 2023€92.1b€157.3b€3.3b11.7x28.1x0.6x
Sun, 19 Feb 2023€99.2b€157.9b€10.9b9.6x9.1x0.6x
Tue, 17 Jan 2023€100.0b€157.9b€10.9b9.6x9.2x0.6x
Price to Earnings Ratio

9.2x


Total Market Cap: €100.0bTotal Earnings: €10.9bTotal Revenue: €157.9bTotal Market Cap vs Earnings and Revenue0%0%0%
German Chemicals Industry Price to Earnings3Y Average -130.8x202420252026
Current Industry PE
  • Investors are relatively neutral on the German Chemicals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 0.68x.
Past Earnings Growth
  • Total earnings for the Chemicals industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 9.0% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the German Materials industry?

DE Market2.60%
Materials2.00%
Chemicals0.57%
Fertilizers and Agricultural Chemicals1.11%
Specialty Chemicals0.85%
Diversified Chemicals0.42%
Commodity Chemicals-0.22%
Industry PE
  • Investors are most optimistic about the Diversified Chemicals industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 23.9%, which is higher than its past year's earnings decline of 6.4% per year.
Forecasted Growth
  • Analysts are most optimistic on the Fertilizers and Agricultural Chemicals industry, expecting annual earnings growth of 108% over the next 5 years.
  • In contrast, the Commodity Chemicals industry is expected to see its earnings grow by 8.0% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SY1 Symrise€70.062.5%
+€237.6m		-29.0%PE19.3x
BAS BASF€44.940.4%
+€141.5m		8.2%PE128.6x
ACT AlzChem Group€166.605.8%
+€92.9m		160.3%PE27.2x
LXS LANXESS€17.861.9%
+€29.4m		-20.7%PS0.3x
SDF K+S€12.731.1%
+€25.1m		17.4%PS0.6x

Latest News

EVK
€13.24
Evonik Industries
7D
-0.5%
1Y
-18.8%

EVK: Pricing And Volume Execution Risk Will Pressure Future Earnings

Analysts have cut their implied fair value for Evonik Industries from €17.50 to €11.60. This reflects a series of recent downgrades and lower price targets as they question the company’s ability to protect pricing and grow volumes in line with earlier expectations.
UZU
€73.00
Uzin Utz
7D
2.8%
1Y
49.6%
ACT
€166.60
AlzChem Group
7D
5.8%
1Y
160.3%

ACT: New Creatine Capacity Expansion And 2025 Record Outlook Will Support Upside

Analysts now set a higher fair value target for AlzChem Group at €179.93 compared with €167.10 previously. They point to updated assumptions for revenue growth, profit margins and a lower future P/E multiple.
SY1
€70.06
Symrise
7D
2.5%
1Y
-29.0%

SY1: Margin Strength And Discount Assumptions Will Support Future Upside

Analysts have trimmed their average price targets for Symrise, with recent cuts from €108 to €105 and from €93 to €91.60, reflecting slightly higher discount rate assumptions and only marginal tweaks to long term growth and margin expectations. Analyst Commentary Recent research suggests that, even with slightly lower price targets, opinions on Symrise remain split between those who see upside potential and those who prefer to stay cautious.
WCH
€70.75
Wacker Chemie
7D
-1.0%
1Y
11.6%

WCH: Fair Outlook Hinges On Restructuring Execution And Section 232 Outcome

Analysts have kept their fair value estimate for Wacker Chemie broadly unchanged at €67.36, with only modest tweaks to discount rate, growth and margin assumptions. They have also tempered their stance in light of mixed recent coverage and a Neutral rating with a €73 price target.
LXS
€17.86
LANXESS
7D
1.9%
1Y
-20.7%

LXS: Earnings Resilience And Portfolio Actions Will Drive Bullish Repricing

Narrative Update The updated analyst price target framework for LANXESS points to a fair value adjustment from €31.85 to €29.24. This reflects recent target cuts from €21 to €15 at JPMorgan, a downgrade to Underweight with a €15 target at Barclays, and a reduction from €26 to €23 at Citi that collectively signal increased caution among analysts.
IBU
€21.50
IBU-tec advanced materials
7D
6.4%
1Y
233.9%
SDF
€12.73
K+S
7D
1.1%
1Y
17.4%

SDF: Persistent Price Cuts Will Signal Further Downside Risk Ahead

The analyst price target for K+S has been revised modestly lower, to a range of about EUR 10 to EUR 12.70, as analysts factor in softer near term growth expectations, alongside improved margin assumptions and a lower anticipated future price to earnings multiple. Analyst Commentary Bearish analysts have highlighted that the latest price target reductions reflect a more cautious stance on K+S, with limited upside seen from current trading levels.
BAS
€44.94
BASF
7D
0.4%
1Y
8.2%

BAS: Coatings Sale Will Leave Limited Upside As Cyclical Headwinds Persist

Analysts have modestly raised their price target on BASF to EUR 52.00, citing a more favorable margin outlook supported by the sale price achieved for the coatings business, which came in ahead of expectations. Analyst Commentary While the latest coverage restart with a Buy rating and a EUR 52 price target underscores improved confidence in BASF's margin trajectory, sentiment across the broader analyst community remains mixed.
BNN
€2.75
BRAIN Biotech
7D
6.2%
1Y
-21.0%

Market Cool On BRAIN Biotech AG's (ETR:BNN) Revenues Pushing Shares 28% Lower

Dec 22
Market Cool On BRAIN Biotech AG's (ETR:BNN) Revenues Pushing Shares 28% Lower
2HRA
€4.27
H&R GmbH KGaA
7D
-0.2%
1Y
13.9%
SIM0
€50.50
SIMONA
7D
-1.0%
1Y
-1.9%